Valuation: LivaNova PLC

Market Cap 4.45B 3.91B 3.6B 3.37B 6.32B 420B 6.44B 43.23B 16.75B 207B 16.72B 16.35B 720B P/E 2026 *
29.2x
P/E 2027 * 25.2x
Enterprise Value 4.47B 3.93B 3.62B 3.38B 6.35B 422B 6.46B 43.43B 16.82B 208B 16.8B 16.43B 723B EV / Sales 2026 *
2.97x
EV / Sales 2027 * 2.66x
Free-Float
98.44%
Yield 2026 *
-
Yield 2027 * -
1 day+2.18%
1 week+3.27%
Current month+10.14%
1 month+7.78%
3 months+27.71%
6 months+29.29%
Current year+32.11%
1 week 77.74
Extreme 77.74
82.66
1 month 71
Extreme 71.005
82.66
Current year 56.44
Extreme 56.44
82.66
1 year 41.02
Extreme 41.015
82.66
3 years 32.48
Extreme 32.48
82.66
5 years 32.48
Extreme 32.48
93.89
10 years 32.48
Extreme 32.48
131.54
Manager TitleAgeSince
Chief Executive Officer 53 2024-02-29
Director of Finance/CFO 56 2020-10-30
Investor Relations Contact - 2022-07-31
Director TitleAgeSince
Director/Board Member 69 2015-10-18
Chairman 74 2021-06-08
Director/Board Member 62 2019-06-17
Date Insider Type Main position Quantity % Market Cap.
06-14Fiscal year

Director

10,953 0.0199%
06-14Fiscal year

Director

7,811 0.0142%
06-14Fiscal year

Director

10,953 0.0199%
Change 5-day change 1-year change 3-year change Capi.($)
+2.24%+3.27%+77.48%+64.61% 4.45B
+1.52%+7.93%-29.08%-12.64% 162B
+1.13%+1.80%-6.36%-7.24% 103B
+1.79%+7.82%-1.38%+55.78% 55.83B
-2.09%-6.13%+51.65%+53.01% 54.05B
+2.87%+10.15%-8.81%-39.57% 41.71B
+1.56%+10.40% - - 31.94B
+0.78%+0.80%-18.13%-44.13% 26.49B
+0.26%+5.32%+58.56%-4.88% 24.48B
+1.43%+7.30%-10.03%+1.22% 20.52B
Average +1.22%+1.85%+12.65%+7.35% 52.5B
Weighted average by Cap. +1.23%+2.27%-3.93%+1.12%

Financials

2026 *2027 *
Net sales 1.51B 1.32B 1.22B 1.14B 2.14B 142B 2.18B 14.64B 5.67B 70.15B 5.66B 5.54B 244B 1.61B 1.42B 1.31B 1.22B 2.29B 152B 2.33B 15.67B 6.07B 75.07B 6.06B 5.93B 261B
Net income 146M 128M 118M 111M 208M 13.8B 211M 1.42B 550M 6.8B 549M 537M 23.64B 179M 157M 145M 135M 254M 16.88B 259M 1.74B 673M 8.32B 672M 657M 28.92B
Net Debt 20.06M 17.62M 16.23M 15.18M 28.47M 1.89B 28.99M 195M 75.44M 933M 75.32M 73.67M 3.24B -167M -147M -135M -126M -237M -15.76B -241M -1.62B -628M -7.77B -627M -614M -27.01B
Logo LivaNova PLC
LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, and Neuromodulation. Its Cardiopulmonary segment is engaged in the design, development, manufacture, marketing, and sale of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories. Its Neuromodulation segment is engaged in the design, development, manufacture, marketing, and sale of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). Its principal Neuromodulation product, the VNS Therapy System, consists of an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals.
Employees
3,300
Date Price Change Volume
26-06-26 US$81.53 +0.59% 49,314
26-06-25 US$81.05 +1.38% 652,150
26-06-24 US$79.95 +1.61% 822,050
26-06-23 US$78.68 -0.04% 576,237
26-06-22 US$78.71 +0.27% 689,739
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
81.05USD
Average target price
81.50USD
Spread / Average Target
+0.56%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. LIVN Stock